Iron Sucrose (Venofer) 100–200mg IV
Brand names: Venofer
Iron sucrose (Venofer) is an intravenous iron preparation widely used to treat iron deficiency anaemia in chronic kidney disease, particularly in haemodialysis patients, where oral iron is poorly absorbed or insufficient.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It supplies an iron-sucrose complex that is taken up by the reticuloendothelial system and incorporated into transferrin and ferritin, restoring iron available for haemoglobin synthesis.
Prescribing in practice
- Give only where staff and equipment to treat anaphylaxis are immediately available, and observe the patient during and after administration for hypersensitivity.
- Administer by slow intravenous injection or infusion, as rapid administration can cause hypotension.
- Avoid in the first trimester of pregnancy and use later in pregnancy only when clearly necessary.
Monitoring
Monitor haemoglobin and iron indices to assess response and avoid iron overload, especially with repeated dialysis-unit dosing.
Counselling the patient
- Tell staff at once about any rash, wheeze, dizziness or facial swelling during the injection.
- Skin can stain if the drug leaks at the injection site, so report pain or burning there.
- Several doses may be required to fully replenish your iron stores.
Evidence & guidelines
Renal anaemia guidance supports intravenous iron such as iron sucrose as first-line iron replacement in haemodialysis-dependent CKD.
Reference: KDIGO Anaemia in CKD Guidelines 2012; Venofer SPC; NICE NG203; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019